Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Implementation of an Evidence-Based Care Pathway for Emergency Department Management of Sickle Cell Vaso-Occlusive Crisis Leads to Improved Clinical Outcomes

Jennifer Yui, MD, Scott A. Peslak, MD PhD, David Lambert, MD, Eric Russell, MD, Farzana Sayani, MD

Blood (2019) 134 (Supplement_1): 4678.

https://doi.org/10.1182/blood-2019-123868

Published: 2019

Journal Articles

Patient-Reported Outcome Measures (PROMs) in Pediatric Non-Malignant Hematology: A Systematic Review

Robert J Klaassen, MD FRCPC, Julia Y. Kinahan, MDcal Student, Johann M. I. Graham, MDcal Student, Yamilée V. Hébert, MDcal Student, Katie O'Hearn, MSc Human Kinetics

Blood (2019) 134 (Supplement_1): 2180.

https://doi.org/10.1182/blood-2019-127248

Published: 2019

Journal Articles

Home-Based Assessment of Patient Reported Outcome Measures Using a Smartphone App Platform: A Feasibility Study

Sherif M. Badawy, MD, Leonardo Barrera, MPH, Graham Zolkowski, BS, Zeinab Alward, MBChB, MPH

Blood (2019) 134 (Supplement_1): 420.

https://doi.org/10.1182/blood-2019-131334

Published: 2019

Journal Articles

Development of a Virtual Benign Hematology Consultation Service: Results of a Pilot Project Involving 5 Medical Centers

Ashok Pai, MD, Dinesh Kotak, MD, Nancy Facher, MPH, MS, Kyle Reader, MHA, Kevin Kong, Natalya Greyz, MD, Jahan Tavakoli, MD, Alfredo R. Lopez, MD, Jerome G. Kim, MD, Daniel Maloney, MD, Raymond Liu, MD, Tatjana Kolevska, MD

Blood (2018) 132 (Supplement 1): 824.

https://doi.org/10.1182/blood-2018-99-110009

Published: 2018

Journal Articles

FLT3 and NPM1 Are Powerful Determinants of Outcome in Acute Myeloid Leukemia Patients Treated with Autologous Stem Cell Transplantation: An Analysis By the Acute Leukemia Working Party of the EBMT

Roni Shouval, MD PhD, Myriam Labopin, MD, David Bomze, MSc, Gabriela M Baerlocher, Robin Foà, MD, Didier Blaise, Mathias Haenel, MD, Edouard Forcade, MD, Anne Huynh, MD, Riccardo Saccardi, MD, Giuseppe Milone, MDPhD, Tsila Zuckerman, MD, Péter Reményi, MD, Jordi Esteve, MD PhD, Norbert Claude Gorin, MDPhD, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2018) 132 (Supplement 1): 609.

https://doi.org/10.1182/blood-2018-99-111614

Published: 2018

Journal Articles

Initial Results from a Phase 1 Clinical Study of bb21217, a Next-Generation Anti Bcma CAR T Therapy

Nina Shah, MD, Melissa Alsina, MD, David S Siegel, MD PhD, Sundar Jagannath, MD, Deepu Madduri, MD, Jonathan L Kaufman, MD, Ashley Turka, Lyh Ping Lam, PharmD, RPh, Monica Massaro, MPH, Kristen Hege, MD, Fabio Petrocca, MD, Jesus G. Berdeja, MD, Noopur Raje, MD

Blood (2018) 132 (Supplement 1): 488.

https://doi.org/10.1182/blood-2018-99-116953

Published: 2018

Journal Articles

Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials)

Pratima Chowdary, MD, Lone Hvitfeldt Poulsen, Miguel A Escobar, MD, Susan Kearney, Meera B. Chitlur, MD, Robert Klamroth, Mudi Misgav, Claude Negrier, Wan Hui Ong Clausen, Frank Driessler, Andrea Landorph, Elena Santagostino

Blood (2018) 132 (Supplement 1): 1177.

https://doi.org/10.1182/blood-2018-99-110308

Published: 2018

Journal Articles

Under-Reporting of Patient Reported Outcome (PRO) in Clinical Trials

Liat Vidal-Fisher, MD MSc, Kelly K. Curtis, MD, Laura Vidal, MD, Keren R. Moss, MD

Blood (2018) 132 (Supplement 1): 3583.

https://doi.org/10.1182/blood-2018-99-114464

Published: 2018

Journal Articles

Beyond ABR: High FIX Activity Levels Translate into Clinical Benefits over Standard Prophylaxis

Guy Young, Manuel Carcao, MDMSc, Susan Kearney, MD, Stephanie Valer Seremetis, MD, David L Cooper, MD

Blood (2017) 130 (Supplement 1): 2372.

https://doi.org/10.1182/blood.V130.Suppl_1.2372.2372

Published: 2017

Journal Articles

Provision of Long-Term Monitoring and Late Effects Services Following Hematopoietic Cell Transplantation (HCT): A Survey of European Programs By the Complications and Quality of Life Working Party of the EBMT

Nina Salooja, DM, FRCP, FRCPath, Steffie van der Werf, MSc, Maura Faraci, MD, Angela Hamblin, MDPhD, Anja van Biezen, Grzegorz W. Basak, MD PhD, Rafael F. Duarte, MD PhD

Blood (2016) 128 (22): 4607.

https://doi.org/10.1182/blood.V128.22.4607.4607

Published: 2016

Journal Articles

Feasibility of a Smartphone-Based Health Coaching Intervention for Patient Self-Management of Nutrition in the Post-Chemotherapy Setting

Connie E Chen, MD, Alice Y Mao, Jontrice G Murray, Betul Oran, MD, Muzaffar H. Qazilbash, MD, Nina Shah, MD, Sairah Ahmed, MD, Qaiser Bashir, MD, Chitra Hosing, MD, Elizabeth J. Shpall, MD, Joseph R Steele, MD, Richard E. Champlin, MD, Simrit Parmar, MD

Blood (2016) 128 (22): 3554.

https://doi.org/10.1182/blood.V128.22.3554.3554

Published: 2016

Journal Articles

Treatment Use Study of Platelet Components Treated with Amotosalen and Ultraviolet a Light in Response to Emerging Arboviruses in Puerto Rico - True Study Final Results

Salvador Rico, Susan L. Stramer, PhD, Richard J. Benjamin, MD PhD, Edgardo Cartagena, Axel Arroyo, Nelson Robles, Simon Carlo, L Vera, P Solivan-Ortiz, Norman Huang, Claudia Koontz, Travis Berry, Laurence Corash

Blood (2016) 128 (22): 3844.

https://doi.org/10.1182/blood.V128.22.3844.3844

Published: 2016

Journal Articles

An Integrated Genomic Classification That Includes Copy Number Alterations Is Highly Predictive of Post Induction Minimal Residual Disease (MRD) Status in Childhood Precursor B Lineage Acute Lymphoblastic Leukemia

Nikhil Patkar, MD, Papagudi Ganesan Subramanian, MD, Prashant Tembhare, MD, Pratibha Amare Kadam, PhD, Asma Bibi, MD, Karishma Chopra, MSc, Satish Mirgal, MSc, Sagar Rambhiya, MSc, Swapnali Joshi, MSc, Shruti Chaudhary, PhD, Russel Mascrenhas, MSc, Sona Dusseja, MSc, Gaurav Narula, MD, Brijesh Arora, DM, Shripad Banavali, MD, Sumeet Gujral, MD

Blood (2015) 126 (23): 2615.

https://doi.org/10.1182/blood.V126.23.2615.2615

Published: 2015

Journal Articles

Value-Based Health Care (VBHC) in Sickle Cell Disease: A Dutch Initiative

Fia ten Brink, MD, Anita W. Rijneveld, MD PhD, Marie-José J.A.G. Claessen, MD, Amando J. Heesterman, Thea J. van Zon, Sonja A.M.C. Teuben, Cora J.D. Onna Van - Walraven, Alice M.A. Goncalves Silva, Francis van Veelen, Renée du Mortier, Marieke A.M.S. Joosten, MD PhD, Fred Petrij, MD PhD, Jan A. Hazelzet, MD PhD, Marjon H. Cnossen, MD PhD

Blood (2015) 126 (23): 5572.

https://doi.org/10.1182/blood.V126.23.5572.5572

Published: 2015

Journal Articles

Fibrinolysis Times As Outcome Measures Using ROTEM with Tpa-Induced Fibrinolysis in Chemotherapy Induced Thrombocytopenia

Paul JL Heuvelmans, BSc, Floor CJI Moenen, MD, Ron JMHE Straat, Rick JH Wetzels, Yvonne MC Henskens, MSc PhD, Erik AM Beckers, MDPhD

Blood (2015) 126 (23): 4738.

https://doi.org/10.1182/blood.V126.23.4738.4738

Published: 2015

Journal Articles

The Prognostic Value of Molecular Bone Marrow Involvement in Aggressive Lymphoma

Neta Goldschmidt, MD, Fares Darawshy, Elena Slyusarevsky, Galina Pogrebijski, Dina Ben Yehuda, Moshe E. Gatt, MD

Blood (2015) 126 (23): 1450.

https://doi.org/10.1182/blood.V126.23.1450.1450

Published: 2015

Journal Articles

Higher Doses of Antithymocyte Globulin (ATG) Increase the Risk of Relapse in Acute Myeloid Leukemia (AML) Patients Undergoing Matched Related Donor Allogeneic Transplantation in First Complete Remission (CR1): An Analysis from the Acute Leukemia Working Party of EBMT

Raynier Devillier, MD, Myriam Labopin, MD, Patrice Chevallier, MD PhD, Bruno Lioure, MD PhD, Gerard Socie, MD PhD, Anne Huynh, MD, Jean-Henri Bourhis, MD, Jean-Yves Cahn, MD PhD, Mauricette Michallet, MD PhD, Laure Vincent, MD, Frederic Baron, Didier Blaise, MD PhD, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2014) 124 (21): 729.

https://doi.org/10.1182/blood.V124.21.729.729

Published: 2014

Journal Articles

A Systematic Review of Definitions and Reporting of Bleeding Outcome Measures in Hemophilia

Chatree Chai-Adisaksopha, MD, Christopher M. Hillis, MD FRCPC, Lehana Thabane, PhD, Alfonso Iorio, MD PhD

Blood (2014) 124 (21): 2821.

https://doi.org/10.1182/blood.V124.21.2821.2821

Published: 2014

Journal Articles

Psychological Factors Associated With Episodic Oral Chelation Adherence In Thalassaemia

Vosper Jane, D Clin Psy, Michael Evangeli, Clin Psy D, John Porter, MD, Farrukh Shah, MD

Blood (2013) 122 (21): 4706.

https://doi.org/10.1182/blood.V122.21.4706.4706

Published: 2013

Journal Articles

Comparative Effectiveness and Safety Of Pathogen Inactivated (Amotosalen-UVA) and Conventional Plasma For Treatment Of Auto-Immmune Thrombotic Thrombocytopenic Purpura (TTP): A 15-Year Retrospective Review

Raoul Herbrecht, MD, Mario Ojeda-Uribe, MD, Daniel Kientz, MD, Alain Bohbot, MD, Olivier Hinschberger, MD, Cecile Fohrer, MD, Kun-Lun Liu, MD, Emilie Remy, Christine Ernst, MD, Laurence Corash, MD, Jean-Pierre Cazenave, MD, PhD

Blood (2013) 122 (21): 4820.

https://doi.org/10.1182/blood.V122.21.4820.4820

Published: 2013

NARROW

Implementation of an Evidence-Based Care Pathway for Emergency Department Management of Sickle Cell Vaso-Occlusive Crisis Leads to Improved Clinical Outcomes

Patient-Reported Outcome Measures (PROMs) in Pediatric Non-Malignant Hematology: A Systematic Review

Home-Based Assessment of Patient Reported Outcome Measures Using a Smartphone App Platform: A Feasibility Study

Development of a Virtual Benign Hematology Consultation Service: Results of a Pilot Project Involving 5 Medical Centers

FLT3 and NPM1 Are Powerful Determinants of Outcome in Acute Myeloid Leukemia Patients Treated with Autologous Stem Cell Transplantation: An Analysis By the Acute Leukemia Working Party of the EBMT

Initial Results from a Phase 1 Clinical Study of bb21217, a Next-Generation Anti Bcma CAR T Therapy

Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials)

Under-Reporting of Patient Reported Outcome (PRO) in Clinical Trials

Beyond ABR: High FIX Activity Levels Translate into Clinical Benefits over Standard Prophylaxis

Provision of Long-Term Monitoring and Late Effects Services Following Hematopoietic Cell Transplantation (HCT): A Survey of European Programs By the Complications and Quality of Life Working Party of the EBMT

Feasibility of a Smartphone-Based Health Coaching Intervention for Patient Self-Management of Nutrition in the Post-Chemotherapy Setting

Treatment Use Study of Platelet Components Treated with Amotosalen and Ultraviolet a Light in Response to Emerging Arboviruses in Puerto Rico - True Study Final Results

An Integrated Genomic Classification That Includes Copy Number Alterations Is Highly Predictive of Post Induction Minimal Residual Disease (MRD) Status in Childhood Precursor B Lineage Acute Lymphoblastic Leukemia

Value-Based Health Care (VBHC) in Sickle Cell Disease: A Dutch Initiative

Fibrinolysis Times As Outcome Measures Using ROTEM with Tpa-Induced Fibrinolysis in Chemotherapy Induced Thrombocytopenia

The Prognostic Value of Molecular Bone Marrow Involvement in Aggressive Lymphoma

Higher Doses of Antithymocyte Globulin (ATG) Increase the Risk of Relapse in Acute Myeloid Leukemia (AML) Patients Undergoing Matched Related Donor Allogeneic Transplantation in First Complete Remission (CR1): An Analysis from the Acute Leukemia Working Party of EBMT

A Systematic Review of Definitions and Reporting of Bleeding Outcome Measures in Hemophilia

Psychological Factors Associated With Episodic Oral Chelation Adherence In Thalassaemia

Comparative Effectiveness and Safety Of Pathogen Inactivated (Amotosalen-UVA) and Conventional Plasma For Treatment Of Auto-Immmune Thrombotic Thrombocytopenic Purpura (TTP): A 15-Year Retrospective Review

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only